WASHINGTON — Drug makers are ramping up their defense of Medicare’s prescription drug program with a new ad campaign set to launch in D.C. publications next week.
The “Let’s talk about Medicare” campaign from the industry’s main lobbying group, PhRMA, targets the Part D program, which covers seniors’ prescription costs.
The industry’s biggest goal is to take aim at pharmacy benefit managers, the “middlemen” that PhRMA says should have to “share the savings” with seniors, as it says in the ad. The Trump administration has been considering a related policy change often referred to as “point of sale” rebates. PhRMA has also been engaged in a fight to convince Congress to reduce how much pharmaceutical companies have to pay for some seniors’ prescription costs in the Part D program next year.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect